We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+3.27%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$477M
AUM Growth
-$8.91M
Cap. Flow
-$21.5M
Cap. Flow %
-4.51%
Top 10 Hldgs %
33.08%
Holding
125
New
9
Increased
29
Reduced
73
Closed
5

Top Sells

Rank Stock Value
1
OTTR icon
Otter Tail
OTTR
+$5.75M
2
ADM icon
Archer Daniels Midland
ADM
+$3.95M
3
BCE icon
BCE
BCE
+$2.77M
4
GVA icon
Granite Construction
GVA
+$2.59M
5
DUK icon
Duke Energy
DUK
+$2.47M

Sector Composition

Rank Sector Weight
1 Healthcare 26.1%
2 Industrials 18.87%
3 Technology 18.27%
4 Utilities 8.95%
5 Energy 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$646B
$22.4M 4.69%
194,432
-3,825
-2% -$442K
GLW icon
2
Corning
GLW
$128B
$21.8M 4.56%
897,068
-4,118
-0.5% -$97.9K
EMR icon
3
Emerson Electric
EMR
$86.6B
$17.1M 3.57%
306,050
-23,683
-7% -$1.27M
XOM icon
4
ExxonMobil
XOM
$644B
$16.3M 3.42%
180,670
-13,402
-7% -$1.17M
PFE icon
5
Pfizer
PFE
$159B
$14.9M 3.13%
484,149
-17,743
-4% -$542K
SLB icon
6
SLB Ltd
SLB
$85.1B
$14.7M 3.08%
175,112
-6,535
-4% -$536K
GVA icon
7
Granite Construction
GVA
$5.44B
$13.5M 2.84%
246,102
-48,838
-17% -$2.59M
INTC icon
8
Intel
INTC
$473B
$12.7M 2.66%
349,753
-5,172
-1% -$185K
MRK icon
9
Merck
MRK
$366B
$12.6M 2.65%
225,133
-2,594
-1% -$152K
LNN icon
10
Lindsay Corp
LNN
$1.16B
$11.9M 2.49%
159,132
-8,000
-5% -$634K
AZTA icon
11
Azenta
AZTA
$1.44B
$9.47M 1.98%
554,674
-71,226
-11% -$1.07M
TEL icon
12
TE Connectivity
TEL
$58.7B
$9.34M 1.96%
134,800
-2,500
-2% -$166K
WMT icon
13
Walmart Inc
WMT
$820B
$8.28M 1.73%
359,400
-6,600
-2% -$154K
IBM icon
14
IBM
IBM
$222B
$8.13M 1.7%
51,206
-722
-1% -$110K
BMY icon
15
Bristol-Myers Squibb
BMY
$136B
$8.05M 1.69%
137,684
-719
-0.5% -$39.3K
GM icon
16
General Motors
GM
$75.7B
$7.94M 1.66%
227,961
-10,239
-4% -$344K
TT icon
17
Trane Technologies
TT
$98.8B
$7.82M 1.64%
104,234
-2,770
-3% -$200K
ABT icon
18
Abbott
ABT
$195B
$7.67M 1.61%
199,571
+6,300
+3% +$250K
NVS icon
19
Novartis
NVS
$292B
$7.65M 1.6%
117,140
+57,229
+96% +$3.71M
HON icon
20
Honeywell
HON
$68.9B
$6.99M 1.46%
66,749
-1,554
-2% -$158K
DUK icon
21
Duke Energy
DUK
$93.8B
$6.8M 1.43%
87,631
-32,307
-27% -$2.47M
MSFT icon
22
Microsoft
MSFT
$3.81T
$6.76M 1.42%
108,867
-2,325
-2% -$140K
COP icon
23
ConocoPhillips
COP
$157B
$6.64M 1.39%
132,385
+3,150
+2% +$145K
BNS icon
24
Scotiabank
BNS
$113B
$6.24M 1.31%
112,100
-1,000
-0.9% -$54.5K
OGE icon
25
OGE Energy
OGE
$9.45B
$6.05M 1.27%
181,001
-6,684
-4% -$211K

Similar funds

John G. Ullman & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, John G. Ullman & Associates held 125 positions worth $477M, down 1.8% from $486M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates withdrew a net $21.5M in Q4 2016, closing 5 positions and reducing 73 holdings. Its most notable exit was Scana, an estimated $2.43M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Industrials and Technology.

Against the trend, John G. Ullman & Associates opened a new position in CalAmp Corp. worth $2.62M.

  • John G. Ullman & Associates's largest Q4 2016 buy was CalAmp Corp.: 7,852 shares worth $2.62M.
  • John G. Ullman & Associates added most to Novartis in Q4 2016, an estimated $3.71M increase.
  • John G. Ullman & Associates's biggest Q4 2016 reduction was Otter Tail, cutting an estimated $5.75M.
  • John G. Ullman & Associates fully exited Scana in Q4 2016, selling an estimated $2.43M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $477M portfolio in Q4 2016.
  • John G. Ullman & Associates opened 9 new positions and closed 5 in Q4 2016.
  • John G. Ullman & Associates's portfolio value fell 1.8% quarter-over-quarter to $477M.

Based on John G. Ullman & Associates's 13F filing for Q4 2016, filed 20 Jan 2017.